Flyte

Flyte

Freedom from bladder leaks. in reach. | Flyte by Pelvital USA.

HQ location
Minneapolis, United States
Launch date
Employees
Enterprise value
$9—14m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor

€0.0

round
*

$2.3m

Seed
Total Funding000k
More about Flyte
Made with AI
Edit

Flyte by Pelvital offers a revolutionary at-home treatment for stress urinary incontinence, targeting women who experience bladder leaks, particularly after childbirth or during athletic activities. The company operates in the healthcare market, focusing on non-invasive solutions for pelvic floor strengthening. Flyte's core product is an intravaginal device that uses mechanotherapy and biofeedback to amplify the benefits of Kegel exercises, making them 39 times more effective. The device is designed to be used for just 5 minutes a day over a 6-week period, with a 90% user satisfaction rate for ease of use. Flyte generates revenue through direct sales of its device and offers a money-back guarantee if users do not see improved bladder control within six weeks. Additionally, the company provides free consultations with a pelvic floor physical therapist and educational resources through its Flyte Notes newsletter.

Keywords: stress urinary incontinence, pelvic floor, mechanotherapy, biofeedback, intravaginal device, Kegel exercises, bladder control, non-invasive treatment, women's health, healthcare innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo